Current pharmacologic testing for horner syndrome
- Mansoor Mughal
- , Reid LongmuirAffiliated withDepartment of Ophthalmology and Visual Sciences, The University of Iowa Hospitals and Clinics Email author
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
First described in 1727, Horner syndrome occurs from injury to one of the three neurons in the oculo-sympathetic pathway. Its presence can be confirmed with pharmacologic testing, traditionally including cocaine testing with hydroxyamphetamine localization. More recently, apraclonidine testing has become a viable alternative in some practices. Concern has been raised regarding the possibility of false-negative results with apraclonidine testing as well as the safety of its use in young children.
- Current pharmacologic testing for horner syndrome
Current Neurology and Neuroscience Reports
Volume 9, Issue 5 , pp 384-389
- Cover Date
- Print ISSN
- Online ISSN
- Current Science Inc.
- Additional Links